What did @thatsarajane actually say?
Honestly? Not much, medically speaking. The transcript is song lyrics, specifically Natasha Bedingfield's "Unwritten," sung over what the caption tells us is a transformation video. The actual claim lives in the caption: @thatsarajane says not recognising her own face, describing it as a "giant moon head," was one of the signals she had gained significant weight before starting Mounjaro. This is a before-and-after framing, not a medical tutorial. She is not prescribing, diagnosing, or advising. She is documenting a personal experience of facial weight changes associated with obesity and subsequent GLP-1 treatment. That context matters when we assess what is actually being communicated here.
The phrase "gone a custard cream too far" is British slang for having gained more weight than she intended. The video presents facial change as a marker of that weight gain, and implicitly, as evidence that Mounjaro has reversed it.
Does the science back this up?
Yes, within limits. Fat redistribution in the face is real, measurable, and documented in people with obesity. And GLP-1 receptor agonists do produce facial fat loss as part of systemic weight reduction. What the science does not support is treating facial changes as a diagnostic tool or a reliable weight loss metric.
Facial adipose tissue responds to caloric deficit and weight loss, including weight loss induced by tirzepatide, the active ingredient in Mounjaro. A 2023 trial published in The New England Journal of Medicine (Jastreboff et al., 2022, NEJM) found tirzepatide produced mean weight reductions of 15 to 22.5 percent at 72 weeks depending on dose. At those levels of loss, facial volume changes are not cosmetically subtle. Plastic surgeons have started calling this "GLP-1 face" in popular media, though that term has no formal clinical definition. The underlying physiology, subcutaneous facial fat loss with potential skin laxity, is well established in bariatric literature independently of the drug class.
So the creator is not wrong. She is just not being precise, which is fine for a personal video.
What did they get wrong (or right)?
She got the experiential truth right. Facial puffiness or fullness is a legitimate and documented feature of higher body weight, and its reduction is a genuine, if informal, marker that weight loss is occurring. Credit where it is due: she is not claiming Mounjaro fixed her health, cured anything, or recommending a dose. That restraint is better than a lot of what circulates in the GLP-1 content space.
What she skips, understandably for a 30-second TikTok, is nuance. Facial fat loss on GLP-1s is not uniformly flattering. Jastreboff and colleagues' data, alongside observational reports from dermatologists, suggests that rapid or significant weight loss can cause facial volume loss that some patients find ageing. A 2020 paper by Rohrich et al. in Plastic and Reconstructive Surgery documented how facial fat compartments deflate unevenly with systemic fat loss, which can create hollowing around the temples and midface. She shows a happy outcome. Not everyone's is.
There is also no mention of the rate of loss, which matters clinically. Fast facial change on a GLP-1 can also reflect muscle loss alongside fat loss if protein intake is inadequate, something the video does not touch.
What should you actually know?
If you are on a GLP-1 like tirzepatide or semaglutide and your face is changing, that is probably weight loss working, not a side effect to panic about. But a few things are worth knowing that this video does not cover.
- Facial fat loss on GLP-1s is real and documented, but the rate matters. Losing more than 1 to 1.5 percent of body weight per week increases the risk of muscle loss alongside fat, which can affect facial structure differently than pure fat reduction.
- "GLP-1 face" is a media term, not a clinical diagnosis. Dermatologists and plastic surgeons are observing patterns, but there is no standardised clinical framework yet for managing it.
- Skin laxity after significant facial fat loss is a documented outcome in bariatric patients (Shermak et al., 2006, Plastic and Reconstructive Surgery). GLP-1-induced losses may produce similar results, particularly in patients over 45 or those with significant total weight loss.
- If facial changes concern you, a dermatologist or your prescribing clinician is the right person to ask, not TikTok comment sections.
@thatsarajane is sharing her experience, and that has value. But personal transformation videos are not a substitute for monitored clinical care.